These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 15073814)

  • 1. Could preferential prescribing and referral behaviour of physicians explain the elevated thrombosis risk found to be associated with third generation oral contraceptives?
    Heinemann LA; Lewis MA; Assmann A; Gravens L; Guggenmoos-Holzmann I;
    Pharmacoepidemiol Drug Saf; 1996 Sep; 5(5):285-94. PubMed ID: 15073814
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of prescribing and referral bias in studies of the association between third generation oral contraceptives and increased risk of thromboembolism.
    Dunn N; White I; Freemantle S; Mann R
    Pharmacoepidemiol Drug Saf; 1998 Jan; 7(1):3-14. PubMed ID: 15073741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Venous and arterial thrombosis during oral contraceptive use: risks and risk factors.
    Tanis BC; Rosendaal FR
    Semin Vasc Med; 2003 Feb; 3(1):69-84. PubMed ID: 15199494
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk of nonfatal venous thromboembolism with oral contraceptives containing norgestimate or desogestrel compared with oral contraceptives containing levonorgestrel.
    Jick SS; Kaye JA; Russmann S; Jick H
    Contraception; 2006 Jun; 73(6):566-70. PubMed ID: 16730485
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The truth about oral contraceptives and venous thromboembolism.
    Shulman LP; Goldzieher JW
    J Reprod Med; 2003 Nov; 48(11 Suppl):930-8. PubMed ID: 14686030
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of progestagens on activated protein C (APC) resistance among users of oral contraceptives.
    Alhenc-Gelas M; Plu-Bureau G; Guillonneau S; Kirzin JM; Aiach M; Ochat N; Scarabin PY
    J Thromb Haemost; 2004 Sep; 2(9):1594-600. PubMed ID: 15333036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence of venous thromboembolism in young Swedish women and possibly preventable cases among combined oral contraceptive users.
    Samuelsson E; Hägg S
    Acta Obstet Gynecol Scand; 2004 Jul; 83(7):674-81. PubMed ID: 15225194
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of sex and traditional cardiovascular risk factors on the risk of recurrent venous thromboembolism: results from the German MAISTHRO Registry.
    Linnemann B; Zgouras D; Schindewolf M; Schwonberg J; Jarosch-Preusche M; Lindhoff-Last E
    Blood Coagul Fibrinolysis; 2008 Mar; 19(2):159-65. PubMed ID: 18277138
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence of arterial cardiovascular events in patients with idiopathic venous thromboembolism. A retrospective cohort study.
    Bova C; Marchiori A; Noto A; Rossi V; Daniele F; Santoro C; Ricchio R; De Lorenzo R; Umbaca R; Prandoni P
    Thromb Haemost; 2006 Aug; 96(2):132-6. PubMed ID: 16894454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Specific oral contraceptive use and venous thromboembolism resulting in hospital admission.
    Heuser P; Tonga K; Hopkins R; Henderson M; Weatherall M; Metcalfe S; Beasley R
    N Z Med J; 2004 Nov; 117(1206):U1176. PubMed ID: 15570345
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dental screening and referral of young children by pediatric primary care providers.
    dela Cruz GG; Rozier RG; Slade G
    Pediatrics; 2004 Nov; 114(5):e642-52. PubMed ID: 15520094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk of venous thromboembolic disease associated with hormonal contraceptives and hormone replacement therapy: a clinical review.
    Gomes MP; Deitcher SR
    Arch Intern Med; 2004 Oct; 164(18):1965-76. PubMed ID: 15477430
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk of deep vein thrombosis: interaction between oral contraceptives and high factor VIII levels.
    Legnani C; Cini M; Cosmi B; Poggi M; Boggian O; Palareti G
    Haematologica; 2004 Nov; 89(11):1347-51. PubMed ID: 15531457
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Venous thromboembolic disease in users of low-estrogen combined estrogen-progestin oral contraceptives.
    Sidney S; Petitti DB; Soff GA; Cundiff DL; Tolan KK; Quesenberry CP
    Contraception; 2004 Jul; 70(1):3-10. PubMed ID: 15208046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Individualization of low-dose oral contraceptives. Pharmacological principles and practical indications for oral contraceptives].
    Cianci A; De Leo V
    Minerva Ginecol; 2007 Aug; 59(4):415-25. PubMed ID: 17923832
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral contraceptives and the absolute risk of venous thromboembolism in women with single or multiple thrombophilic defects: results from a retrospective family cohort study.
    van Vlijmen EF; Brouwer JL; Veeger NJ; Eskes TK; de Graeff PA; van der Meer J
    Arch Intern Med; 2007 Feb; 167(3):282-9. PubMed ID: 17296885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thromboembolism during hormone therapy in Japanese women.
    Adachi T; Sakamoto S
    Semin Thromb Hemost; 2005 Jun; 31(3):272-80. PubMed ID: 16052396
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral contraceptives, hormone therapy and cardiovascular risk.
    Shapiro S
    Climacteric; 2008 Oct; 11(5):355-63. PubMed ID: 18781479
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Obesity and risk of venous thromboembolism among postmenopausal women: differential impact of hormone therapy by route of estrogen administration. The ESTHER Study.
    Canonico M; Oger E; Conard J; Meyer G; Lévesque H; Trillot N; Barrellier MT; Wahl D; Emmerich J; Scarabin PY;
    J Thromb Haemost; 2006 Jun; 4(6):1259-65. PubMed ID: 16706969
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myocardial infarction and oral contraceptives, a retrospective case control study in England and Scotland ('MICA' Study).
    Dunn NR; Thorogood M; de Caestecker L; Mann RD
    Pharmacoepidemiol Drug Saf; 1997 Jul; 6(4):283-9. PubMed ID: 15073780
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.